A recent study claimed that the COX7B is a potential novel gene target for FH treatment (Li et al., 2015); however, authors did not provide supportive evidence for metabolic network and pathway links between the Atherosclerosis and FH. Here, COX7B is linked to familial hyperaldosteronism.